The GLP-1 receptor antagonist reduced all levels of hypoglycemia, by different measures, and in patients who had undergone different bariatric surgery procedures.
Exendin-(9-39) may offer some children born with this rare disease, which results in excessively low blood glucose, an alternative to near-total pancreatectomy.